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The infectious bronchitis virus (IBV) nucleocapsid protein was expressed as a bacterial fusion protein which differed from
the native protein only in the addition of six amino terminus histidine residues. Using RNA overlay protein blot assays, the
recombinant protein was shown to bind to RNA fragments specific for the positive sense 3* noncoding end of the IBV
genome. At greater concentrations of sodium chloride, the native and fusion nucleocapsid proteins similarly bound to G
RNA, representing the terminal 1805 3* nt of the genome, whereas bovine serum albumin and allantoic fluid protein did not
bind to labeled G RNA. Competitive gel shift assays with labeled G RNA indicated that the protein interacted with several
unlabeled RNA representing sequences at the 3* noncoding end of the IBV genome. Cache Valley virus (a bunyavirus)
mRNA transcribed from the small segment cDNA also inhibited the interaction with IBV G RNA to approximately the same
extent as homologous unlabeled G RNA, whereas reactions with bovine liver RNA and yeast tRNA were considerably
weaker. Whereas yeast tRNA did not inhibit the interaction with the labeled large G RNA, interactions of the fusion protein
with EF, a region from 78 to 217 nt from the 3* terminus of the IBV genome, were also apparently weaker than interactions
with fragment CD which consisted of the 3* terminal 155 nt. On a molar basis, the latter interacted in an identical nature
to a RNA consisting of CD and an additional 1053 nt of plasmid sequences. Compared to bovine liver RNA, unlabeled G
specifically inhibited binding to the two smaller labeled IBV fragments in gel shift assays. The binding of IBV nucleocapsid
protein with RNA probably requires specific sequences and/or structures that are present on the genome, and may represent
a common mechanism used by similar viral nucleoproteins whose functions depend on binding to RNA. q 1996 Academic
Press, Inc.
INTRODUCTION The MHV nucleocapsid protein specifically binds to small
leader-containing RNAs, and within the cytosol of MHV-
The nucleocapsid protein of the avian coronavirus, in- infected cells it can interact with membrane-bound small
fectious bronchitis virus (IBV), is a highly basic, phos- leader RNA in transcription complexes (Stohlman et al.,
phorylated structural protein of 409 residues or about 50 1988). Anti-nucleocapsid monoclonal antibodies report-
kDa (Boursnell et al., 1985; Williams et al., 1992). Coro- edly precipitate both full-length and subgenomic mRNA,
navirus nucleocapsid sequences vary among major anti- as well as replicative intermediate RNA (Baric et al.,
genic groups but are highly conserved within these 1988). The amount of protein found associated with the
groups (Williams et al., 1992). The amino acid sequences genome and the putative functions of this protein sug-
of various IBV strains are greater than 94% conserved. In gested that it could readily associate with additional re-
addition, the proteins are more conserved in the central gions of coronavirus RNA.
region than at the ends. A highly basic region in the IBV Because transcription of the negative template must
protein between residues 238 and 293 is identical among
initiate at the 3* end of genomic RNA and because nu-
the strains that have been examined (Williams et al.,
cleocapsid protein may be involved, it is likely that the
1992). The corresponding region of mouse hepatitis virus
3* noncoding region will also readily associate with this
(MHV) has been shown to bind to RNA (Masters, 1992;
protein. A relatively A-U-rich hypervariable region (HVR)
Nelson and Stohlman, 1993).
with an as yet undefined function can be found in the 3*In addition to being closely associated with the RNA
noncoding region of nearly all IBV strains (Williams etgenome, the coronavirus nucleocapsid protein has been
al., 1993). This study examined the association of a re-shown to be involved in transcription and possibly in
combinant IBV nucleocapsid protein with the 3* end oftranslation (Robbins et al., 1986; Compton et al., 1987;
the IBV genome, representing the terminal 1805 nt, andStohlman et al., 1988; Baric et al., 1988; Masters, 1992).
overlapping 151- to 256-nt fragments representing the
noncoding region. Enriched nucleocapsid recombinant
protein, obtained with an Escherichia coli expression1 To whom correspondence and reprint requests should be ad-
dressed. vector were used in competitive binding gel shift assays
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that indicated the nucleocapsid protein specifically inter- lar proteins. The recombinant nucleocapsid protein was
eluted with sonication buffer, pH 7, supplemented withacts with several regions of the 3* noncoding terminus
of the IBV genome. 250 mM imidazole. Two-milliliter fractions were collected
from the column, and fractions containing the recombi-
nant protein were concentrated using an Amicon centri-MATERIALS AND METHODS
prep 10 concentrator (Amicon, Beverly, MA). Western blot
Cloning into the pQE8 expression vector assays were used to compare native nucleocapsid pro-
tein prepared from purified Gray strain IBV grown in em-The nucleocapsid gene of the IBV Gray strain was
bryonating chicken eggs (Sneed et al., 1989) with theexcised from a pCR1000 recombinant plasmid (Williams
fusion protein.et al., 1992) using BamHI and ligated into the pQE8 ex-
pression vector with T4 DNA ligase (Promega, Madison,
Source of RNAWI). M15/pRep4 cells were then transfected with the
plasmid construct by electroporation at 12.5 kV/cm for 5 The in vitro transcripts were produced from the
msec (Sambrook et al., 1989; BTX, San Diego, CA; Qia- pCR1000 and the pGEM3Z vectors with the T7 promoter
gen, Chatsworth, CA). The IBV cDNA inserts were then (Promega, Madison, WI). Inserts specific for selected
sequenced using Sequenase kit (USB, Cleveland, OH) to fragments of the 3* end of the Gray genome were ob-
determine the orientation and to confirm the fidelity of tained by cDNA cloning of PCR products (produced using
the nucleocapsid sequence. Taq polymerase from Promega, Madison, WI) that corre-
sponded to the sequences of interest. In addition, BamHI
Expression and enrichment of the recombinant or HindIII sites were inserted downstream of the tran-
nucleocapsid gene script with the amplifying primers. The resulting PCR
products were cloned into the pCR1000 vector through
Single colonies containing the pQE8 with nucleocap-
the A overhang resulting from the polymerase reaction
sid cDNA insert were grown in LB media with ampicillin
or into the pGEM3Z vector following restriction enzyme
and kanamycin according to the Qiagen manual and pro-
digestion (Sambrook et al., 1989). Electroporation (de-
tein expression was induced with IPTG (Qiagen, Chats-
scribed above) was used to transform JM109 cells (Stra-
worth, CA). The fusion protein was expressed in cells
tagene, La Jolla, CA) with the constructed plasmids.
collected from 1 ml of the culture fluid, and analyzed by
Template plasmids containing specific IBV sequences
SDS–PAGE following Coomassie blue staining, while
were linearized by digesting with BamHI before ex-
IBV specificity of the fusion protein was determined by
tracting with phenol/chloroform and precipitating with
Western blot analysis using primary chicken anti-IBV and
ethanol (Sambrook et al., 1989). Transcription was car-
secondary goat anti-chicken antibodies (Sneed et al.,
ried out as described in the Promega Protocol and Appli-
1989; Parr and Collisson, 1993).
cations Guide (Promega) with T7 RNA polymerase and
For cytosolic localization, the fusion protein was in-
the transcripts, terminated at the 3*-incorporated BamHI
duced in 100-ml cell cultures as described in the Qiagen
or HindIII sites, were labeled by the addition of [a32P]CTP
manual (Qiagen, Chatsworth, CA). Immediately prior to
(NEN, Boston, MA). Cache Valley virus (CVV) RNA, used
and following induction of protein, 1-ml samples were
as competitor, was produced by transcribing BamHI-di-
taken from the cultures and stored in lysing buffer before
gested S segment cDNA that had been cloned into
separating the proteins by SDS–PAGE. The cells from
pGEM3Z (Chung, 1992). Transcripts with 1052 nt of plas-
induced cultures were harvested by centrifugation at
mid RNA were also prepared following PstI digestion
4000 1 g for 10 min and the pellet was resuspended in
of pCR1000 plasmids (Sambrook et al., 1989). The RNA
5 ml sonication buffer (50 mM NaH2PO4, pH 8, 300 mM products were quantitated by comparing the ethidium
NaCl), supplemented with 1 mg/ml lysozyme, and kept on
bromide-stained samples with known standards of yeast
ice for 5 min before processing for cytosolic localization.
tRNA (Promega). Bovine liver RNA (ribosomal RNA) used
Cells from a 1-liter culture were induced and pelleted
as a control was obtained from Sigma Chemical Co. (St.
as described above and resuspended in 6 ml of sonica-
Louis, MO).
tion buffer supplemented with 1 mg/ml lysozyme (Qiagen
manual, Qiagen, Chatsworth, CA). The sample was incu- RNA overlay protein blot analysis (ROPBA)
bated for 5 min on ice before adding 0.66 ml 3 M NaCl
and incubating on ice for another 5 min. The cells were RNA sequences binding to the nucleocapsid proteins
(whole virus or synthetic preparations) and control pro-sonicated for 5 min on ice and centrifuged at 10,000 g
for 30 min. The supernatant was collected and loaded teins (bovine serum albumin or egg allantoic proteins)
were detected by ROPBA (Robbins et al., 1986; Sambrookonto an 8-ml Ni2/-NTA column (Qiagen, Chatsworth, CA)
preequilibrated with sonication buffer. The column was et al., 1989). Proteins (4.2 mg/well) were separated by
SDS–PAGE on a 10% acrylamide gel and transferred towashed with 10 vol of sonication buffer supplemented
with 20 mM imidazole to reduce the background of cellu- nitrocellulose. The nitrocellulose membrane blots were
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washed for 30 min at room temperature in SBB buffer
(0.05 to 0.3 M of NaCl, 10 mM Tris, pH 7, 1 mM EDTA,
0.02% bovine serum albumin, 0.02% Ficoll, and 0.02%
polyvinyl pyrrolidone). Strips of the blots were placed in
petri dishes containing 4 ml SBB and 2 1 105 cpm of
[a32P]CTP-radiolabeled RNA (approximately 10 ng RNA).
Bovine liver RNA was added to a final concentration of
20 mg/ml to remove nonspecific binding. After 1 hr at
room temperature with constant agitation, strips were
thoroughly washed with SBB and dried, and the bound
RNA was then visualized by autoradiography. The inte-
grated optical densities of the bands were quantitated
with a BioImage Visage Image Analysis System with Sun
Sparc 10 Workstation (Ann Arbor, MI).
FIG. 2. Comparison of the purified, concentrated recombinant protein
with the native protein from gradient purified virus by (a) SDS–PAGEGel-shift analysis
and (b) Western blot. In a, lane 1 represents the marker protein stan-
dards; 2, recombinant protein; 3, native protein; 4, egg allantoic protein;Protein–RNA interactions were analyzed by a modified
and 5, bovine serum albumin. In b, lane 1 represents recombinantgel-shift assay (Chodosh, 1992). One ng of RNA and vary-
protein; 2, native protein; 3, egg allantoic protein; and 4, bovine serum
ing concentrations of nucleocapsid protein were coincu- albumin.
bated for 20 min at room temperature in 10 ml of gel-shift
buffer (25 mM Hepes, 25 mM EDTA, 150 mM NaCl, 5
mM DTT, 10% glycerol, and 20 units rRNasin, Boehringer to obtain quantities of relatively enriched protein used
Mannheim Corp., Indianapolis, IN). Following the addi- for studying interactions with RNA. A protein band corre-
tion of 1 ml 101 sample buffer, the reaction mixtures sponding to the expected 50-kDa position was seen in
were loaded onto a 0.5% (larger RNA fragment) or 1% the IPTG-induced cultures by 3 hr and peaked at 5 hr
agarose gel (smaller fragments) and electrophoresed at (data not shown). Induced and uninduced samples from
60 V in 11 Tris–borate– EDTA (Sambrook et al., 1989). clone 68 obtained 5 hr following exposure to IPTG are
Gels were then dryed and autoradiographed. Competi- shown in Fig. 1. The soluble cytoplasmic fraction was
tion assays were performed using a constant 3.0 mg of used as the source for the IBV nucleocapsid fusion pro-
nucleocapsid protein and a mixture of 1 ng of [a32P]CTP- tein.
radiolabeled RNA as indicated and varying concentra- The fusion protein with tandem histidine residues at
tions of unlabeled homologous or heterologous competi- the amino terminus was enriched from the soluble cyto-
tor RNA. plasmic fraction by Ni2/-NTA affinity chromatography.
Figure 2 shows that in an SDS–polyacrylamide gel, the
RESULTS migration of recombinant nucleocapsid protein was simi-
lar to that of native nucleocapsid protein derived fromRecombinant nucleocapsid protein
IBV. Moreover, both recombinant and native proteins re-
Nucleocapsid protein from the Gray strain of IBV was acted with anti-IBV serum in a Western blot assay (Fig.
expressed in a pQE8 bacterial expression vector in order 2). Anti-IBV antibody did not react with bacterial proteins.
In addition to the whole nucleocapsid protein, smaller
bands could sometimes be seen in the Western blot
assay in the recombinant protein lane. The reaction of
smaller polypeptides with the anti-IBV antisera sug-
gested that they were produced by premature termina-
tion of translation. As the histidine tag is at the amino
terminus of the protein, any such premature termination
products would be absorbed onto the column and thus
copurified with the full-length nucleocapsid protein (Qia-
gen Manual). Alternatively, they could have originated
from proteolysis.
RNA binding to immobilized protein
FIG. 1. Crude protein preparations of uninduced (lanes 1 and 2) and
The ROPBA was used to initially determine potentialinduced (lanes 3 and 4) cultures of clone 68 and a bacteria cell control
binding of the synthetic nucleocapsid protein to RNAwithout plasmid (C). The recombinant protein band is indicated by an
arrow. corresponding to regions in the 1805 base 3* terminus
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FIG. 3. (a) Diagram indicating the position of each RNA transcript (right of figure) on the Gray IBV genome. The numbers indicate the nt included
in each transcript as numbered from the 3* end of the genome. (b) DNA template for plasmid control RNA. pCR represents RNA transcribed from
pCR1000 and CD-pCR, RNA transcribed from the pCR1000 with CD cloned into the HindIII site.
of the Gray IBV genome. Positive sense RNAs specific M concentration of sodium chloride, all the radiolabeled
IBV-specific RNA transcripts, including the large G tran-for the 3* noncoding end of the genome were synthesized
as targets for the synthetic nucleocapsid protein binding script, and the smaller I, AB, CD, and EF, bound to the
nucleocapsid protein. The intensity of the radioactivestudies (Fig. 3). RNA G (1805 nt) was transcribed from
the whole nucleocapsid gene, and RNA I represents the RNA signal was greatest at the position on the blot corre-
sponding to full-length recombinant nucleocapsid pro-3* HVR (256 nt). The RNA fragments AB (165 nt), CD (155
nt), and EF (140 nt which partially overlapped with both tein.
ROPBA were repeated with the large G transcriptsAB and CD) represent conserved regions extending from
the HVR to the 3* terminus of the genome. Although G to examine the effects of sodium ion concentration on
interactions of IBV RNA with recombinant and native nu-and CD included the 3* terminus of the genome, neither
included a poly(A) tail. A BamHI site was used to termi- cleocapsid protein. Potential interactions with unrelated
bovine serum albumin and egg allantoic proteins werenate the cDNA template for all transcripts except CD in
which an EcoRI site was used to linearize the plasmid. included as controls. Autoradiographs of the blots and a
graph of the integrated optical intensities of each bandEach IBV-specific RNA fragment was reacted with 4.2
mg of fusion nucleocapsid protein (Fig. 4). Using a 0.05 are shown in Fig. 5. Labeled G interacted similarly with
both recombinant and native nucleocapsid protein at all
concentrations used, whereas no interaction was de-
tected with either bovine serum albumin or egg allantoic
proteins used as protein controls. Because the decrease
in binding of both recombinant and native proteins was
more dose dependent between 0.05 M and 0.1 M and
the recombinant protein bound with somewhat less effi-
ciency at 0.3 M, 0.15 M sodium chloride concentration
was used in additional experiments evaluating protein –
RNA interactions.
Gel shift analysesFIG. 4. RNA overlay protein blot analysis (ROPBA) with recombinant
nucleocapsid protein binding to positive-sense RNA from the 3* end
Gel shift assays were used to further examine protein –of the IBV genome. Each panel shows the reaction with the indicated
RNA interactions to determine relative shifts in mobilitylabeled transcript explained in Fig. 3. Lane N in each panel contains
the synthetic nucleocapsid protein and lane C, the bacterial cell control. of the various species of RNA, including transcripts corre-
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FIG. 5. The effects of sodium chloride concentrations on radiolabeled G RNA interactions with IBV nucleocapsid proteins. (a) The autoradiograph
of the ROPBA in which lane 1 represents the recombinant protein; lane 2, the native proteins; lanes 3 and 4, egg allantoic proteins and bovine
serum albumin, respectively. Panel A represents 0.05 M of sodium chloride; B, 0.1 M; C, 0.2 M; and D, 0.3 M. (b) Integrated optical intensities from
the autoradiographs.
sponding to the 3* terminus of the IBV genome. Interac- Competitive gel shift analyses
tions between G and the fusion protein could be identi-
Competition gel shift assays were done using 3 mg,fied by the decrease in mobility of the radiolabeled RNA
a nonsaturating concentration, of the fusion protein. Inprobe (Fig. 6a). No shift in mobility could be observed
addition to unlabeled RNA representing the various re-when labeled RNA probe was mixed with bovine serum
gions of the 3* terminus of the genome, CVV RNA, yeastalbumin. The effects of protein concentration on forma-
tRNA, and bovine liver RNA were used to compete withtion of G RNA–protein complexes on gel shift assays
the interaction of G RNA and the recombinant nucleocap-were first determined in the absence of competing RNA
sid protein (Fig. 7). Radiolabeled G was mixed with 100(Fig. 6b). The mobility decreased, that is, the size of the
ng of each competing RNA species before reacting withcomplexes increased, with increasing concentrations of
the nucleocapsid protein. Differences could be seen innucleocapsid protein. In the presence of IBV RNA, the
the efficiency of inhibition of G interaction with the nu-greatest concentrations of protein resulted in formation
cleocapsid protein by each RNA species. Yeast tRNAof additional large, megacomplexes that did not migrate
appeared to have no effect on the mobility of radiolabeledinto the gel. No shift in mobility of the labeled RNA was
G, whereas the autologous unlabeled G RNA was mostobserved when reacted with an equivalent concentration
efficient, almost eliminating the protein interaction withof either egg allantoic proteins (Fig. 6a) or bovine serum
labeled G. Surprisingly, CVV RNA, corresponding to thealbumin (data not shown).
positive sense RNA of the small genome segment, ap-
FIG. 7. Gel-shift assay in which the interaction of a-32P-labeled GFIG. 6. Gel-shift assay demonstrating the binding of radiolabeled G
RNA to the synthetic nucleocapsid protein. (a) Free a-32P-labeled G in RNA and recombinant nucleocapsid protein is competed with 100 ng
of unlabeled RNA. Lane 1 represents free labeled G, lane 10 representsthe absence of protein is shown in lane 1, radiolabeled G with 3 mg
bovine serum albumin is shown in lane 2, and the binding of 1 ng labeled G and protein in the absence of competitor RNA, and lane 2,
labeled G with the protein and unlabeled autologous G. Lanes 3 to 9radiolabeled G with 3 mg of nucleocapsid protein is shown in lane 3. (b)
Lanes 1 to 9 show the effects of twofold dilutions of protein beginning in represent labeled G with protein and unlabeled competitor AB, CD, EF,
I, CVV, bovine liver, and yeast RNA, respectively.lane 1 with 20 mg of protein. The free labeled G is shown in lane 10.
AID VY 7752 / 6a11$$$162 02-02-96 11:45:29 vira AP: Virology
196 ZHOU ET AL.
FIG. 8. Competitive gel-shift assay in which the interactions of the recombinant nucleocapsid protein with radiolabeled G RNA are inhibited with
varying concentrations of the unlabeled RNA. The corresponding competitor RNA used is indicated below each autoradiograph. Lanes 1 represent
free labeled G RNA in the absence of protein and competitor, lanes 2 to 6, labeled G with protein and twofold dilutions of competitor beginning
with 100 ng in lane 2, and lane 7 represents labeled G in the presence of protein and no competitor.
peared to bind at least as well, if not better than I, AB, as inhibitors (Fig. 9). No competition of G binding to nu-
cleocapsid protein was observed with pCR RNA, whichand CD. In contrast, the EF region was a very inefficient
inhibitor, comparable in this assay to bovine liver RNA, did not contain IBV sequences (Fig. 9a). Competition with
CD and CD-pCR, an equivalent amount of CD-pCR RNAwhich was of ribosomal origin.
The shifts in G mobility resulting from the interaction was reproducibly (in three separate experiments) less
efficient at interacting with nucleocapsid protein (Figs.of protein were further characterized using varying con-
centrations of unlabeled competing RNA of each species 9b and 9d). Because the molar ratio of CD to CDpCR
was about 8:1, competitive inhibition was also examinedmixed with labeled RNA before the addition of recombi-
nant nucleocapsid protein. The shift in the mobility in with a molar equivalent of CD and CD-pCR RNA (Figs.
9b and 9c). As might be predicted if CD contains bindingthe presence of the competitor was compared with the
maximum shift in the absence of the competitor. Unla- sites for the nucleocapsid protein and therefore specifi-
cally interacts with nucleocapsid competed, the ob-beled G, AB, CD, I, and CVV RNA again appeared to
interact relatively efficiently with the nucleocapsid pro- served inhibition of the two preparations with G was
nearly identical. The IBV sequences within the CD frag-tein, whereas the protein interactions with EF and bovine
liver RNA were relatively inefficient (Fig. 8). All IBV frag- ment specifically interacted with the recombinant protein.
Considering the excess of non-IBV sequences in CD-ments from the 3* end appeared to react with the recom-
binant nucleocapsid protein with relatively high efficiency pCR, the inhibition of this fragment was greater than
might be expected, possibly indicating a degree of non-except the EF fragment which corresponded to nt 78 to
217 from the 3* end of the genome. The efficiency of specific cooperative binding in the presence of specific
binding.interaction with protein appeared to be at least as poor
as that of bovine liver RNA. CVV RNA interactions with In order to further confirm that IBV nucleocapsid pro-
tein interactions with IBV RNA were not the result ofthe nucleocapsid protein did suggest a similar efficiency
in inhibition in mobility to that of the homologous G RNA. nonspecific binding to RNA, competitive gel shift assays
were done with [a32P]CTP-radiolabeled CD or EF RNATranscribed RNA of a similar length as G, a 1052-nt
fragment designated pCR, prepared from PstI-digested and unlabeled G or yeast tRNA. A shift assay using vary-
ing concentrations of recombinant protein reacted withpCR1000, and RNA transcripts from pCR1000 with the
CD immediately downstream of the promoter, a 1207-nt 1 ng of labeled CD or EF indicated that 2 mg represented
a concentration of nonsaturated protein (data not shown).fragment designated CD-pCR (Fig. 3b), were also used
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FIG. 9. Competitive gel-shift assay using pCR RNA (a), CD RNA (b), and CD-pCR RNA (c and d) as competitors. Lane 1. represents 1 ng labeled
G RNA probe, lanes 2 to 6, labeled G with protein and twofold dilutions of competitor beginning with 100 ng (a, b, and d) or 800 ng (c) in lane 2,
and lane 7 represents labeled G in the presence of protein and no competitor.
One nanogram of labeled CD and varying concentrations
of unlabeled G were mixed with 2 mg of the recombinant
protein. A shift in mobility of labeled CD or EF was ob-
served in the presence of protein (Fig. 10). A small, but
reproducible difference in the inhibition of EF and CD
with unlabeled G could be observed, suggesting that EF
interacts somewhat less efficiently than CD. The de-
crease in mobility of EF probes could be inhibited even
with 6.25 ng of cold G. The inhibition of CD mobility was
less affected by the same concentration of G or in parallel
experiments not affected by the addition of unlabeled G
(data not shown). In contrast, the presence of unlabeled
yeast tRNA had no effect on the nucleocapsid protein
associated shift of EF. Although the presence of unla-
beled yeast tRNA had a slight effect on the interaction
with CD, it was not comparable to the inhibition observed
with G. Therefore, the recombinant protein generated in
these experiments specifically interact with the 3* end
of the IBV genome.
DISCUSSION
The nucleocapsid protein of MHV has been shown
to bind specifically to RNA corresponding to its leader
sequence (Stohlman et al., 1988; Nelson and Stohlman,
1993). In this paper, we have shown that the nucleocap-
sid protein of IBV is able to interact with relatively high
affinity to RNA representing specific regions at the 3*
end of the IBV genome. Competitive binding analyses
indicated that the nucleocapsid protein bound with simi-
lar specificity to transcripts which spanned the length of
the entire 3* noncoding region, but the interaction be-
tween the recombinant fusion protein and an overlapping
fragment, from 217 to 78 nts from the 3* terminus, was FIG. 10. Competitive gel-shift assay in which the interactions of 2
mg of recombinant nucleocapsid protein with 1 ng of a-32P-labeled CDcomparatively weaker. The interactions with unlabeled
(a and b) or EF (c and d) were inhibited with unlabeled G (a and c) orRNA indicated that the protein interaction with RNA frag-
yeast tRNA (b and d). Lanes 1 represent 2 ng of free labeled RNA inment EF was consistently less efficient than that with
the absence of protein and competitor RNA, lanes 2 to 6, 1 ng of
autologous labeled G. Therefore, within the positive labeled CD or EF with protein and twofold decreasing concentrations
sense 3* noncoding region, fragments I, AB, CD, and of unlabeled G beginning with 100 ng in lanes 2, and lanes 7 represent
labeled CD or EF in the presence of protein and no competitor.G, as well as the CVV RNA, contained sequences that
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promoted nucleocapsid protein binding under conditions be expected that altered phosphorylation in the eukary-
otic host cell could result in variations of the RNA reac-used in these studies, whereas sequences or structures
required for optimal interactions with nucleocapsid pro- tions of the native protein, it was obvious that this recom-
binant protein was at least functional with respect to itstein were not present or were sufficiently altered in EF
and bovine liver RNA. The interactions of labeled CD and basic interaction with RNA and its antigenicity. Therefore,
it should provide a valuable source for further character-EF with protein were both inhibited by unlabeled G. The
reproducible difference observed in the inhibition of CD ization of the functions of the nucleocapsid in IBV replica-
tion.and EF with G might also suggest that EF interacts less
efficiently than CD. Inhibition with the relatively large G The nucleocapsid protein used in these experiments
appeared to interact preferentially to specific sequencesmay produce a less sensitive assay for comparing inter-
actions with the nucleocapsid protein than inhibitions and/or structures found on the IBV genome, as well as
the RNA of at least one other virus. These interactionswith the unlabeled smaller fragments. In addition, unlike
the competitive studies with labeled G, partial inhibition may be indicative of a common strategy for certain viral
protein interactions with viral RNA. The RNA of CVV mayof the smaller fragments could be observed, that is, the
labeled RNA migrated both at the position of free RNA have structures or sequences that not only interact with
IBV nucleocapsid protein but also may react in a similarand of protein-complexed RNA.
The relative interactions of each RNA fragment might fashion with its own nucleocapsid protein. Computer-
generated comparisons between the G and CVV RNA didbe expected to depend on the number of binding sites,
as well as binding affinity at each site. However, a molar identify a short region of 18 nt of 88% similarity (personal
observations). Putative amino acid sequences of the IBVequivalent of CD and CD-pCR (with a non-IBV 1052-nt
sequence) inhibited G binding in an identical manner. and CVV nucleocapsid protein indicate that both are lack-
ing zinc fingers (Williams et al., 1992; Chung, 1992) andCD appears to encode sequences that can specifically
bind to the nucleocapsid protein although we can not therefore must bind to RNA through a mechanism inde-
pendent of such structures. Although computer gener-rule out the possibility that G encodes additional binding
sites. Correlation of reactivity strictly with fragment size ated hairpin turns can be found in all the fragments used,
requirements for secondary structure or base pairing stillwas not evident, because CD-pCR RNA did not compete
as efficiently as an equivalent amount of G nor on the need to be evaluated.
The nature of the binding between nucleocapsid pro-basis of amount of nucleotides available, as well as CD.
The G fragment of 1807 nt in length, CVV of approximately tein and RNA is not known. Presumably cooperative
binding among multivalent RNA and protein molecules800 nt and CD of 155 nt were most efficient at equivalent
total RNA concentrations. Those RNA transcripts that was responsible for the continuously increasing size
of the complexes resulting from increasing concentra-bound less efficiently included the small yeast tRNA,
1052-nt fragment of pCR1000, 2300- or 4200-nt ribosomal tions of protein. Large complexes that could not enter
the gel were observed at the greater concentrationsRNA of the bovine liver preparation, and sequences in
the 140-nt EF transcripts. The sequences of the latter of protein. Similar concentrations of the recombinant
protein alone as shown by Western blot analyses didwere included within either AB or CD. Therefore, the RNA
sites required for binding to the recombinant nucleocap- not form these megacomplexes (data not shown) which
could also be simulated at the lower concentrationssid protein are not ubiquitous in the genome or in nature
but require a degree of sequence and/or structure speci- of recombinant nucleocapsid protein when spermidine
was added to the reaction mixture (Williams, 1993).ficity.
Since the fusion protein used for these studies had Because these large complexes were not seen in the
absence of RNA, they must be related to interactionstandem histidine residues at the amino terminus and
was produced in a bacterial system, this product would involving both RNA and protein. The increased com-
plexity of the shift in mobility of RNA – protein observednot be expected to be identical to the viral protein synthe-
sized in the eukaryotic host. However, the effects of so- in the presence of the larger G fragment compared
with that in the presence of EF or CD suggests that Gdium ions on G RNA and nucleocapsid interactions sug-
gest that the fusion protein functions at least in some may have more sites of interaction and be capable
of greater cooperative binding with the nucleocapsidrespects as the native protein at salt concentrations be-
low 0.3 M. The difference observed in reactions in the protein. The increased binding of CD on a molar basis
with the addition of pCR RNA (which alone does not0.3 M sodium chloride buffer may reflect alterations in
the binding site(s) of the synthetic protein or the presence bind) may be explained by the presence of cooperative
binding following specific interactions with CD.of additional functional site(s) on the native counterpart.
Differences may also exist in the phosphorylation status Following the presumed binding of viral protein at a
packaging signal sequence on genomic RNA, packagingof the native and synthetic proteins. Any phosphorylation
of the fusion protein would depend on the bacterial cell of the entire genome may dictate the necessity of nucleo-
capsid protein binding in a cooperative manner to re-or less likely on autophosphorylation. Although it might
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